The administration of MSCs promoted hyperglycemia reversion, pancreatic islet repair, insulin production improvement, regulatory T (Treg) cell expansion and inflammatory process reduction in MSC-treated diabetic animals [7,14-21]. Here, INS is linked to Hyperglycemia.